COVID-19 Trials in Chicago, United States
Conditions / COVID-19 / Chicago, United States
Research into COVID-19 spans multiple therapeutic approaches and trial phases.
94 total trials for this combination
Showing top 10 of 94 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04516746 | Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults | COMPLETED | PHASE3 |
| NCT04292730 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment | COMPLETED | PHASE3 |
| NCT05815498 | A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 | COMPLETED | — |
| NCT04292899 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) | COMPLETED | PHASE3 |
| NCT05815498 | A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 | COMPLETED | — |
| NCT05822583 | Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial | COMPLETED | PHASE4 |
| NCT04401579 | Adaptive COVID-19 Treatment Trial 2 (ACTT-2) | COMPLETED | PHASE3 |
| NCT06178991 | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza. | COMPLETED | PHASE3 |
| NCT04640168 | Adaptive COVID-19 Treatment Trial 4 (ACTT-4) | COMPLETED | PHASE3 |
| NCT05605093 | Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir) | TERMINATED | PHASE3 |